Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Interest & Investment Income (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Interest & Investment Income of $7.3 million in Q2 2026, up 350.2% from $1.62 million a year earlier and up 9.7% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Interest & Investment Income (2010 - 2026) Analysis & Trends

On a TTM basis, Ligand Pharmaceuticals' Interest & Investment Income came in at $24.22 million as of Jun 30, 2026, up 263.1% year-over-year; for FY2025, it came in at $13.66 million, up 69.6% from FY2024.

  • Annual Interest & Investment Income has increased for four straight years, with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $8.06 million in FY2024 (+4.5%), $7.71 million in FY2023 (+276.9%), $2.05 million in FY2022 (+130.9%) and $886,000 in FY2021 (-89.0%).
  • The Q2 2026 figure is the highest quarterly Interest & Investment Income since Q3 2019.
  • On a year-over-year basis, Interest & Investment Income has increased for four consecutive quarters, with growth averaging 120.6% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 970.9% in Q1 2023, against a decline of 82.9% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.66 million (Q1 2026), $6.39 million (Q4 2025) and $3.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 7.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.30 Mn
Mar 31, 2026 6.66 Mn
Dec 31, 2025 6.39 Mn
Sep 30, 2025 3.87 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.77 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 1.35 Mn
Jun 30, 2024 2.76 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 1.69 Mn
Sep 30, 2023 2.26 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 1.44 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 591,000.00
Jun 30, 2022 298,000.00
Mar 31, 2022 134,000.00
Dec 31, 2021 188,000.00
Sep 30, 2021 169,000.00
API Access

Ligand Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LGND&period=max&api_key=YOUR_API_KEY